Zuellig Pharma

Healthcare Providers and Services, and Healthcare Technology

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40014599

Informations générales

Localisation

Singapore

Asia

Secteur d'activité

Healthcare Providers and Services, and Healthcare Technology

Type d'organisation

Corporate

Dernière mise à jour

02/10/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2045

Statut

Targets set

Classification

1.5°C

Année cible

2045

Progression vers l'objectif37%
2015 (année de référence)2045
Description complète des objectifs

Overall Net-Zero Target: Zuellig Pharma commits to reach net-zero greenhouse gas emissions across the value chain by 2045. Near-Term Targets: Zuellig Pharma commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year. Zuellig Pharma also commits to reduce absolute scope 3 GHG emissions from fuel and energy related activities, upstream transportation and distribution and waste generated in operations 25% within the same timeframe. Long-Term Targets: Zuellig Pharma commits to reduce absolute scope 1 and 2 GHG emissions 90% by 2045 from a 2021 base year. Zuellig Pharma also commits to reduce absolute scope 3 emissions from purchased goods and services, capital goods, fuel- and energy-related activities, upstream transportation and distribution and waste generated from operations 90% within the same timeframe.

Net-Zero

Statut

Targets set

Année cible

2045

Progression37%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques